Health Care & Life Sciences » Biotechnology | Oncolys BioPharma Inc.

Oncolys BioPharma Inc. | Mutual Funds

Mutual Funds that own Oncolys BioPharma Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
BNY Mellon Asset Mid Small Caps Growth Mother Fund
23,000
0.19%
23,000
1.03%
12/20/2017

About Oncolys BioPharma

View Profile
Address
Toranomon Towers Office
Tokyo Tokyo 105
Japan
Employees -
Website http://www.oncolys.com
Updated 07/08/2019
Oncolys BioPharma, Inc. engages in the research and development of oncolytic viruses, drugs for serious infectious diseases, molecular targeted anti-cancer drugs, and tumor diagnostic agents. It also offers consulting services with regard to the research and development of biotechnology drugs. It operates through the following segments: Pharmaceutical and Diagnostics.